dc.contributor.author
Espinosa-Velasco, María
dc.contributor.author
Reguilón, Marina D.
dc.contributor.author
Bellot, Marina
dc.contributor.author
Nadal-Gratacós, Núria
dc.contributor.author
Berzosa, Xavier
dc.contributor.author
Gómez-Canela, Cristian
dc.contributor.author
Rodríguez-Arias, Marta
dc.contributor.author
Camarasa García, Jordi
dc.contributor.author
Escubedo Rafa, Elena
dc.contributor.author
Pubill Sánchez, David
dc.contributor.author
López Arnau, Raúl
dc.date.issued
2023-03-20T12:52:17Z
dc.date.issued
2023-03-20T12:52:17Z
dc.date.issued
2022-07-13
dc.date.issued
2023-03-20T12:52:17Z
dc.identifier
https://hdl.handle.net/2445/195590
dc.description.abstract
N-ethyl-pentedrone (NEPD, 2-(ethylamino)-1-phenyl-1-pentanone) is one of the latest synthetic cathinone derivatives that emerged into the illicit drug market. This drug has psychostimulant properties and has been related with several intoxications and even fatalities. However, information about the consequences of its acute and repeated consumption is lacking. Thus, the aim of our study was to investigate the behavioral effects after both acute and repeated NEPD exposure as well as the neurochemical changes. Male OF1 mice were treated with an acute dose (1, 3 or 10 mg/kg, i.p.) or received repeated injections of these doses (twice/day, 5 days) of NEPD. Shortly after drug-exposure or during drug-withdrawal, anxiety-like behavior, aggressiveness, social interaction, depressive-like symptoms, body weight and temperature were assessed. Also, monoamine synthesis enzymes, levels of neurotransmitters and their precursors and main metabolites, as well as ΔFosB, were determined in striatum and prefrontal cortex from post-mortem tissue. Acute administration of NEPD induced anxiolytic effects and reduced social exploration whereas during withdrawal after repeated administration the anxiolytic effect had vanished, and the reduced social exploration was still present and accompanied with increased aggressive behavior. Moreover, NEPD (10 mg/kg) induced slight hyperthermia and reduced weight gain during the repeated administration, whereas increased locomotor activity and lack of depressive symptoms were found during withdrawal. This was accompanied by increased plasma corticosterone and decrease in striatal dopamine. Finally, the long-lasting and robust increase in ΔFosB levels found in striatum after NEPD chronic exposure suggests a high risk of dependence. The increased aggressivity and locomotor activity, together with this potential of inducing dependence justify a warning about the risks of consumption of NEPD if translated to humans. Keywords: Addiction; Aggressive behavior; Monoamine levels; N-ethyl-pentedrone; Synthetic cathinones.
dc.format
application/pdf
dc.publisher
Elsevier B.V.
dc.relation
Reproducció del document publicat a: https://doi.org/10.1016/j.pnpbp.2022.110562
dc.relation
Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2022, vol. 117
dc.relation
https://doi.org/10.1016/j.pnpbp.2022.110562
dc.rights
cc-by-nc-nd (c) María Espinosa-Velasco, et al., 2022
dc.rights
https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject
Drugs of abuse
dc.subject
Aggressiveness
dc.title
Repeated administration of N-ethyl-pentedrone induces increased aggression and impairs social exploration after withdrawal in mice
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion